Radical Revelations: Nitrosative Stress and the Endocannabinoid System in Age-Related Disorders
This endocannabinoid system neurodegeneration research review highlights the critical role of ECS in modulating nitrosative stress pathways. Emerging evidence suggests ECS modulation may influence neuroinflammation and progression of age-related…
Understanding Neurotransmitter Systems in Alzheimer’s Disease
Neurotransmitter systems Alzheimer's disease dysfunction plays a key role in cognitive decline. Multiple systems including cholinergic, glutamatergic, and GABAergic are affected. Understanding these systems helps explain treatment challenges.
Medicinal Cannabis Shows Efficacy for Alzheimer’s Palliative Care – Sechat
Cannabis palliative care Alzheimer's offers promising symptom management for agitation, sleep disruption, and appetite loss in dementia. Emerging evidence suggests cannabinoids may address neuroinflammation and behavioral symptoms. This approach supports…
Cannabis-Based Spray Shown Feasible and Safe for Alzheimer’s Agitation in UK Care Homes
The nabiximols Alzheimer agitation trial demonstrated that administering this cannabis-based spray is feasible and safe for patients in UK care homes. Despite challenges, the study showed perfect adherence and no adverse drug reactions. These results…
Three Conference Abstracts Explore Cannabis, Social Isolation, and Dementia Care in Older Adults
Systematic studies of cannabinoid use in older adults are needed given its increasing prevalence. Three 2021 conference abstracts explore cannabis, social isolation, and dementia care. These early findings highlight research gaps and clinical…
Cannabis-Based Spray Shows Early Safety Promise for Alzheimer’s Agitation—But Proof of Efficacy Still Awaited
The nabiximols oromucosal spray feasibility trial demonstrated safe administration in Alzheimer's patients with agitation. Despite challenges, the study showed full adherence and no adverse reactions. These findings support larger trials to evaluate…
Assessment of Clinical Factors Predicting Nabilone Response for Agitation in Alzheimer’s
This study investigates nabilone response predictors in treating agitation in Alzheimer's disease. Researchers analyzed clinical factors influencing treatment outcomes. Understanding these predictors may guide personalized cannabinoid therapy for…
Inhaled CBD Reduces Key Neuroinflammatory Markers in Alzheimer’s Mouse Model
Inhaled cannabidiol neuroinflammation effects were studied in an Alzheimer's mouse model, showing reduced IDO and cGAS expression. This reduction correlated with decreased proinflammatory cytokines. These findings highlight inhaled cannabidiol…
3 Key Findings: Cannabis Alzheimer’s Treatment Study 2025
Cannabis Alzheimer treatment research reveals significant cognitive improvement in patients over 26 weeks. This study used low-dose THC-CBD extract demonstrating safety and efficacy. These findings highlight promising advances in dementia care.
5 Essential Breakthroughs in Cannabis Neuromodulation
5 Essential Breakthroughs in Cannabis Neuromodulation Imagine a world where a simple plant could revolutionize the way we treat some of the most challenging health issues, from anxiety and depression to Alzheimer's and Parkinson's disease.…